RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Evidence-Based Decision Making and Health Technology Assessment

      한글로보기

      https://www.riss.kr/link?id=A105871912

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      In health care, technologies should be diffused and adapted if their safety and efficacy has been established and determined. The role of making such a decision, that is whether the safety and efficacy of a certain technology is established, is encaps...

      In health care, technologies should be diffused and adapted if their safety and efficacy has been established and determined. The role of making such a decision, that is whether the safety and efficacy of a certain technology is established, is encapsulated within the processes of a “health technology assessment (HTA).” In this way,HTA has had a central role in the development of a transient healthcare, which is constantly adapting to meet ever-evolving demands. HTA is a very useful concept and tool for providing information for evidence-based decision making. And evidence-based decision making is critical when resources should be allocated in health care. Therefore, from all interest parties in society, the consensus on the necessity for conducting HTA should be brought. And governments should incorporate results from HTA into policy making as possible as they can.

      더보기

      참고문헌 (Reference)

      1 I Kamae, "Value-based approaches to healthcare systems andpharmacoeconomics requirements in Asia" 28 : 831-, 2010

      2 D Banta, "The development of health technology assessment" 63 : 121-, 2003

      3 F Sassi, "Setting priorities for the evaluation of healthinterventions: when theory does not meet practice" 63 : 141-, 2003

      4 "International network of agencies for health technology assessment"

      5 O Golan, "Health technologyprioritization: which criteria for prioritizing new technologiesand what are their relative weights" 102 : 126-, 2011

      6 M Perleth, "Health technology assessment inGermany. Status, challenges, and development" 16 : 412-, 2000

      7 PJ Feldstein, "Health Care Economics" DelmarPublishers 2002

      8 SH Park, "Evidence-based decision-making andhealth technology assessment in South Korea" 11 : S163-, 2008

      9 W Claudia, "Evaluations of health interventions insocial insurance-based countries" 63 : 187-, 2003

      10 JE Stiglitz, "Economics" W. W. Norton& Company 2002

      1 I Kamae, "Value-based approaches to healthcare systems andpharmacoeconomics requirements in Asia" 28 : 831-, 2010

      2 D Banta, "The development of health technology assessment" 63 : 121-, 2003

      3 F Sassi, "Setting priorities for the evaluation of healthinterventions: when theory does not meet practice" 63 : 141-, 2003

      4 "International network of agencies for health technology assessment"

      5 O Golan, "Health technologyprioritization: which criteria for prioritizing new technologiesand what are their relative weights" 102 : 126-, 2011

      6 M Perleth, "Health technology assessment inGermany. Status, challenges, and development" 16 : 412-, 2000

      7 PJ Feldstein, "Health Care Economics" DelmarPublishers 2002

      8 SH Park, "Evidence-based decision-making andhealth technology assessment in South Korea" 11 : S163-, 2008

      9 W Claudia, "Evaluations of health interventions insocial insurance-based countries" 63 : 187-, 2003

      10 JE Stiglitz, "Economics" W. W. Norton& Company 2002

      11 Office of Technology Assessment, "Development of medical technology : opportunities for assessment" U.S. Government Printing Office 1976

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      학술지등록 한글명 : 조직공학과 재생의학
      외국어명 : Tissue Engineering and Regenerative Medicine
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-10-01 평가 등재학술지 선정 (기타) KCI등재
      2012-01-01 평가 등재후보 1차 FAIL (기타) KCI등재후보
      2011-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2010-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2008-01-01 평가 SCIE 등재 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.08 0.42 0.81
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.69 0.51 0.367 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼